Rallybio's total assets for Q3 2024 were $79.01M, a decrease of -14.52% from the previous quarter. RLYB total liabilities were $8.19M for the fiscal quarter, a -34.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.